Navigation Links
Statins Might Stave Off Alzheimer's
Date:6/30/2009

In animal study, drug blocks cell death characteristic of the disease

TUESDAY, June 30 (HealthDay News) -- Treatment with a cholesterol-lowering drug might protect against Alzheimer's disease, new research suggests.

Scientists have long known that nerve cells in people with Alzheimer's die prematurely because they are strongly overstimulated, a process called excitotoxicity.

Theorizing that the cholesterol drug lovastatin might ward off cell death, researchers at the University of Groningen, The Netherlands, conducted animal experiments in which they administered lovastatin (Altoprev, Mevacor) to overstimulated nerve cells. Lovastatin is a first-generation member of a class of drugs, statins, that has revolutionized the treatment of high cholesterol.

Lovastatin did indeed prevent cell death and, just as important, blocked the loss of memory that accompanies excitotoxicity, according to the lead scientist on the project, Amalia Dolga. Earlier, Dolga had shown that statins seem to stimulate the protective capacity of tumor necrosis factor, a key player in the brain's immune response. In addition, some researchers have speculated that high cholesterol might be a risk factor for Alzheimer's, suggesting that lowering cholesterol could be beneficial.

The findings are in the June issue of the Journal of Alzheimer's Disease.

Alzheimer's disease affects more than 5 million people in the United States. The degenerative disease attacks brain cells and ruins memory and thinking. It is the leading cause of dementia and the seventh-leading cause of death in the United States, according to the Alzheimer's Association.

No cure has been found, but treatments have been shown to improve a person's quality of life.

More information

The Alzheimer's Association has more on Alzheimer's disease.



-- Peter West



SOURCE: IOS Press, news release, June 22, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Statins can protect against Alzheimers disease, according to new study
2. Statins May Not Protect Against Pneumonia
3. Statins dont lower risk of pneumonia in elderly
4. A Substitute for Those Who Cant Take Statins?
5. Statins Can Help Prevent Second Stroke
6. Statins alter prostate cancer patients PSA levels
7. Statins Guard Against Prostate Cancer
8. Statins may exert influence on prostate cancer growth by reducing inflammation
9. Many Who Should Use Statins Dont
10. Statins May Help Before Artery-Opening Surgery
11. Study Finds Millions More May Benefit From Statins
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statins Might Stave Off Alzheimer's
(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor , ... Richard Pedranti Architect (RPA), a full-service architecture firm focusing on sustainable design, ... Line of Model Homes . Independently, Ecocor and RPA have extensive experience with ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... inaugural SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student ... MS in Educational Leadership and Administration at St. Thomas University in Miami, Florida, ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Cursed with a Curse: ... tithe, and the freedom experienced when breaking free from this misconception. “Cursed with ... M. Harrison. , Published by Christian Faith Publishing, Lysa M. Harrison’s new book ...
(Date:9/22/2017)... ... , ... "Success Files," a short- and long-form documentary style ... disease estimated to affect the lives of more than 5 million Americans living ... leading voice in the fight for cure and research into the disease, its ...
(Date:9/22/2017)... ... 2017 , ... “Letters From Home”: a moving compilation of letters that ... God. “Letters From Home” is the creation of published author, John Allred, a passionate ... Jerry Savelle Ministries International, who has traveled and ministered on four continents. , “It ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
Breaking Medicine Technology: